The inhibitory effect of RARA could be reversed by overexpression of TXN and PPM1F in both in vivo and in vitro experiments, further highlighting the vital role of inhibiting RARA in the treatment of inducing ferroptosis in cancer. Here, TXN is linked to cancer.